MARKET

NTHI

NTHI

NeOnc Technologies Holdings Inc
NASDAQ
10.75
+0.03
+0.32%
Opening 10:18 02/11 EST
OPEN
10.78
PREV CLOSE
10.72
HIGH
10.95
LOW
10.70
VOLUME
9.31K
TURNOVER
--
52 WEEK HIGH
25.00
52 WEEK LOW
3.200
MARKET CAP
209.43M
P/E (TTM)
-4.1589
1D
5D
1M
3M
1Y
5Y
1D
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 18h ago
Weekly Report: what happened at NTHI last week (0202-0206)?
Weekly Report · 2d ago
New to The Street(R) Airs Tonight on Bloomberg Television Across the U.S., MENA & Latin America
Barchart · 4d ago
NeOnc Technologies files to sell 2.95M shares of common stock for holders
TipRanks · 4d ago
Weekly Report: what happened at NTHI last week (0126-0130)?
Weekly Report · 02/02 09:20
New to The Street Broadcasts Today on Bloomberg Across the U.S., MENA, and Latin America
Barchart · 01/31 04:00
NeOnc Technologies Holdings Gains on $16M Private Investment
Dow Jones · 01/30 17:28
NeOnc Technologies secures strategic PIPE investment from Cinctive Capital
TipRanks · 01/30 14:17
More
About NTHI
NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on establishing treatments for intracranial malignancies, such as aggressive cancers located in the brain. It is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. It is developing novel drug delivery methods to be used in combination with novel drug candidates. The Company has two lead products in development: NEO100 and NEO212. NEO100 is a purified form of perillyl acid (POH) which is administered to brain cancer patients via intranasal delivery. NEO212 is a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol. NEO212 is undergoing development towards intranasal application specifically for patients with uncontrolled brain metastases derived from peripheral tumors (lung, breast, skin, and others).

Webull offers Neonc Technologies Holdings Inc stock information, including NASDAQ: NTHI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NTHI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NTHI stock methods without spending real money on the virtual paper trading platform.